111 (ADR) (YI)
Connects Chinese consumers and pharmacies through digital pharmacy, online care, and supply-chain services.
Something off on this page? Send us feedback.
Connects consumers, pharmacies, and healthcare providers in China through a digital-health platform. Its 1 Pharmacy, 1 Clinic, and 1 Medicine businesses pair consumer access and online care with pharmacy supply, while warehouse partnerships reshape fulfillment.
Operates a China-focused digital-health platform linking consumers, pharmacies, and healthcare providers across China through 1 Pharmacy, 1 Clinic, and 1 Medicine.
1 Pharmacy combines consumer access with an offline virtual-pharmacy network; 1 Clinic offers online consultations and electronic prescriptions; and 1 Medicine supplies pharmacies and other healthcare providers. The model connects online and offline pharmacy services through a supply-chain platform.
The operating model is shifting from owned fulfillment operations toward warehouse partnerships, with commissions and marketplace services intended to carry more of the revenue mechanics. The business remains concentrated in China.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $7.8M · Total debt $6.2M · Total assets $267.1M · Shareholders' equity −$17.1M
- Revenue
- $343.3M
- Operating income
- −$3.5M
- Net income
- −$5.8M
Reported in CNY, converted at the latest exchange rate
No dividends on record.
| Institutions | 0.02% | 36.5K ADS | |
|---|---|---|---|
| 8 holders · as of Jun 30, 2026 | |||
| Insiders | 0.98% | 1.63M ADS | |
| 2 holders · as of Mar 18, 2026 | |||
| Other | 99.00% | 165.37M ADS | |
| remainder | |||
167.03M ADS (1 ADS = 2 ordinary shares) as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
This company has 3 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Junling LiuInsiderdirector | 0.87% | 1.45M A ADS | filed Mar 18, 2026 |
Yu GangInsiderdirector | 0.11% | 176,000 A ADS | filed Mar 18, 2026 |
Citadel Advisors LLCInstitution | 0.01% | 17,339 ADS | as of Jun 30, 2026 |
Renaissance Technologies LLCInstitution | 0.01% | 12,914 ADS | as of Jun 30, 2026 |
Serenus Wealth Advisors, LLCInstitution | 0.00% | 4,320 ADS | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 15, 2026 | Jian David Sun | director | −58,800 | $0.2300 |
| Jun 15, 2026 | Yang Luke Chen | director | −44,000 | $0.2300 |
| Jun 12, 2026 | Yang Luke Chen | director | −49,920 | $0.2300 |
| Jun 11, 2026 | Jian David Sun | director | −111,100 | $0.2300 |
| Jun 10, 2026 | Jian David Sun | director | −115,440 | $0.2200 |
Not reported.